Cellular abnormalities in pituitary tumors

Metabolism: Clinical and Experimental

Volumn 45, Issue SUPPL.1, 1996, Pages 46-48

  Spada, Anna ^a   Lania, Andrea ^a   Mantovani, Simona ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; CORTICOTROPIN; CYCLIC AMP; DIACYLGLYCEROL; DOPAMINE; GONADOTROPIN; GROWTH HORMONE; GUANINE NUCLEOTIDE BINDING PROTEIN; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; PROLACTIN; PROTIRELIN; SOMATOSTATIN; VASOACTIVE INTESTINAL POLYPEPTIDE;

ARTICLE; CALCIUM CELL LEVEL; ENZYME INHIBITION; HORMONE RELEASE; HUMAN; HYPOPHYSIS ADENOMA; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TUMOR GROWTH;

ANIMALS; HUMANS; NEUROTRANSMITTER AGENTS; PITUITARY GLAND; PITUITARY NEOPLASMS;

EID: 0029787098     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(96)90079-7     Document Type: Article

References (24)

1. Billestrup N, Swanson LW, Vale W: Growth hormone releasing factor stimulates cell proliferation of somatotroph in vitro. Proc Natl Acad Sci USA 83:6854-6857, 1986
2. Billestrup N, Mitchell RL, Vale W, et al: Growth hormone releasing factor induces c-fos expression in cultured primary pituitary cells. Mol Endocrinol 1:300-305, 1987
3. Gertz BJ, Contreras LN, McComb DJ, et al: Chronic administration of corticotropin-releasing factor increases pituitary corticotroph number. Endocrinology 120:381-388, 1987
4. Burton FH, Hasel KW, Bloom FE, et al: Pituitary hyperplasia and gigantism in mice caused by a cholera toxin transgene. Nature 350:74-77, 1991
5. Vallar L, Spada A, Giannattasio G: Altered Gs and adenylate cyclase activity in human GH-secreting pituitary adenomas. Nature 330:566-567, 1987
6. Landis C, Masters SB, Spada A, et al: GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumors. Nature 340:692-696, 1989
7. Barkan AL: Acromegaly. Trends Endocrinol Metab 6:205-210, 1992
8. Reichlin S: Etiology of acromegaly from a neuroendocrine point of view; A historical perspective, in Robbins R, Melmed S (eds): Acromegaly. New York, NY, Plenum, 1987, pp 7-15
9. Faglia G, Spada A, Ambrosi B, et al: Central control mechanisms: Their role in the formation of pituitary adenomas, in Landolt AM, Heitz PV, Zapf J, et al (eds): Advances in Pituitary Adenoma Research. Oxford, UK, Pergamon, 1987, pp 77-89
10. Kwekkaboom DJ, De Jong FH, Lamberts SWJ: Gonadotropin release by clinically nonfunctioning and gonadotroph pituitary adenomas in vivo and in vitro. J Clin Endocrinol Metab 68:1128-1135, 1989
11. 2+ in human adenomatous lactoirophs. J Endocrinol Invest 13:13-18, 1990
12. 2+ levels and adenylyl cyclase activity in human non-functioning pituitary adenomas. J Clin Endocrinol Metab 73:913-918, 1991
13. Spada A, Reza-Elahi F, Lania A, et al: Thyrotropinreleasing hormone raises cytosolic free calcium concentration in human adenomatous somatotrophs and corticotrophs; comparison with in vivo responsiveness to thyrotropin-releasing hormone with acromegaly and Cushing's disease. J Neuroendocrinol 3:51-56, 1991
14. Asa SA, Kovacs K, Horvath E, et al: Hormone secretion in vitro by plurihormonal pituitary adenomas of the acidophile cell line. J Clin Endocrinol Metab 75:68-75, 1992
15. Sibley DR, Lefkowitz RJ: Molecular mechanisms of receptor desensitisation using the beta-adrenergic receptor-coupled adenylate cyclase as a model. Nature 317:124-128, 1985
16. Sassolas G, Lejoune H, Trouillas J, et al: Gonadotropinreleasing hormone agonists are unsuccessful in reducing tumoural gonadotropin secretion in two patients with gonadotropinsecreting pituitary adenomas. J Clin Endocrinol Metab 67:180-186, 1988
17. Spada A, Reza-Elahi F, Arosio M, et al: Lack of desensitisation of adenomatous somatotrophs to growth-hormone releasing hormone in acromegaly. J Clin Endocrinol Metab 64:585-591, 1987
18. Lamberts SWJ: The role of somatostatin in the regulation of anterior pituitary hormone secretion and the use of its analogs in the treatment of human pituitary tumours. Endocr Rev 9:417-435, 1988
19. Wood DF, Johnston M, Johnston DG: Dopamine, the dopamine D2 receptors and pituitary tumours. Clin Endocrinol (Oxf) 35:455-466, 1991
20. Liuzzi A, Chiodini PG, Botalla L, et al: Inhibitory effect of L-dopa on GH release in acromegaly. J Clin Endocrinol Metab 35:941-943, 1972
21. Bression D, Brandi AM, Nousbaum A, et al: Evidence of dopamine receptor in human growth hormone (GH)-secreting adenomas with concomitant study of dopamine inhibition of GH secretion in a perifusion system. J Clin Endocrinol Metab 55:589-593, 1982
22. Spada A, Bassetti M, Reza-Elahi F, et al: Differential transduction of dopamine signal in different subtypes of human GH-secreting adenomas. J Clin Endocrinol Metab 78:411-417, 1994
23. Halse J, Harris AG, Kvistorg A: A ramdomised study of SMS 201-995 versus bromocriptine treatment in acromegaly; clinical and biochemical effects. J Clin Endocrinol Metab 70:1254-1261, 1990
24. 2+ concentration decrease in GH4C1 cells. J Biol Chem 265:10320-10326, 1990